Pharmaceutical and healthcare digital advertising surged during the epidemic
As advertising increasingly moves online, pharma and healthcare are taking a bigger share. The industry is expected to spend more than $9.5 billion on digital media this year, according to research firm eMarketer.
The industry's growth rate of more than 14 percent puts it in second place, behind computing products and consumer electronics at 18 percent.
Although the pharmaceutical and healthcare industries have been slower to adopt digital marketing than other industries tracked by eMarketer, the epidemic has accelerated the growth of consumer and professional digital advertising in the sector, the researchers said.
eMarketer expects this trend to continue. By 2021, digital ad spending is expected to grow another 18 percent, to $11.3 billion.
Driving this year's marketing growth, eMarketer says, are digital marketing's pandemic messages on testing and security and related topics, including telemedicine, medical supplies and reopening doctor's offices.
In 2020, more than half (56%) of pharma and healthcare digital spend will be on search ads, with the rest going to display or banner ads.
2026-09-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Can an antibody 'cocktail' prevent COVID-19 infection?
-
Antidumping Pressure Hits the Chemical Chain as Chinese Exports Face Higher Barriers in Europe
-
A $25 Billion Bill Hits Global Companies as Chemical Costs Are Repriced
-
EU Puts Chemicals on Its China De-Risking Watchlist
-
One Million Tonnes of U.S. Ethane Arrive as China Sets a New Import Record
-
IEA Warns Oil Inventories Are Draining Fast as Chemicals Enter Risk Pricing
-
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
-
Wuxi Yinda Nylon Acquires German Century-Old Chemical Giant Perlon
-
Synthomer Sells Its Last Upstream Chemical Business
Recommend Reading
-
Hormuz Is Reopening, But Chemical Logistics May Take Months to Recover
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
European Petrochemical Weakness Leaves Naphtha Oversupplied as Cracker Demand Struggles
-
High Crude Prices Are Passing Through the Coatings Chain as More Than 20 Companies Launch Price Increases
-
Wacker Under Global Cost Pressure: Dual-Track Restructuring Through Layoffs, Consolidation, and Strategic Repositioning
-
Low Levels Across the Entire Cycle Combined with Converging Moving Averages—The Turning Point for Melamine’s Price Decline Is Nearing
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
Chinese Ammonium Sulfate Market Stops Rising and Falls (5.14-5.21)
-
This week, the Chinese urea market showed a weak downward trend (5.15-5.21)
-
Coke Market Prices Remain Stable with a Rising Trend